Alpha Dna Investment Management LLC United Therapeutics Corp Transaction History
Alpha Dna Investment Management LLC
- $261 Million
- Q3 2024
A detailed history of Alpha Dna Investment Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 2,092 shares of UTHR stock, worth $768,517. This represents 0.29% of its overall portfolio holdings.
Number of Shares
2,092
Previous 3,032
31.0%
Holding current value
$768,517
Previous $965,000
22.38%
% of portfolio
0.29%
Previous 0.39%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
669Shares Held
42.8MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.62 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.16 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.05 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$822 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...